Literature DB >> 26211484

Geriatric consultation can aid in complex treatment decisions for elderly cancer patients.

A H W Schiphorst1, D Ten Bokkel Huinink2, R Breumelhof3, J P J Burgmans4, A Pronk1, M E Hamaker5.   

Abstract

Treatment decisions for elderly cancer patients can be challenging. A geriatric assessment may identify unknown medical conditions, give insight on patients' ability to tolerate treatment and guide treatment decisions. Our aim was to study the value of a geriatric consultation in oncological decision-making. Data on cancer patients referred for geriatric consultation for clinical optimisation or due to uncertainty regarding their optimal treatment strategy were prospectively analysed. Outcome of geriatric evaluations, non-oncological interventions and suggested adaptations of oncological treatment proposals were evaluated. Seventy-two patients were referred for consultation, over half of which in a curative treatment setting. Prevalence of geriatric syndromes was 93%, previously undiagnosed conditions were identified in 49% of patients and non-oncological interventions were initiated in 56%. Time was spent discussing patients' priorities (53% of consultations), expectations on treatment (50%) and advance care planning (14%). For 82% of patients, suggestions were made regarding the optimal treatment decision: a more intensive treatment was recommended in 39%, a less intensive therapy for 42% and in 19% only supportive care was suggested. The results demonstrate that a geriatric consultation can aid in complex treatment decisions and may allow for a reduction in over- and undertreatment of elderly cancer patients.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer; evaluation; management; older person; therapy

Mesh:

Year:  2015        PMID: 26211484     DOI: 10.1111/ecc.12349

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

Review 1.  Challenge of cancer in the elderly.

Authors:  Christine Marosi; Marcus Köller
Journal:  ESMO Open       Date:  2016-04-12

2.  Is it time for comprehensive geriatric assessment to move beyond primary care? The case for targeting medical sub-specialty practice.

Authors:  Laura K Byerly; G Michael Harper
Journal:  Isr J Health Policy Res       Date:  2017-06-06

3.  The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer.

Authors:  Karlijn J G Schulkes; Esteban T D Souwer; Marije E Hamaker; Henk Codrington; Simone van der Sar-van der Brugge; Jan-Willem J Lammers; Johanneke E A Portielje; Leontine J R van Elden; Frederiek van den Bos
Journal:  Lung       Date:  2017-03-09       Impact factor: 2.584

4.  Training surgeons in shared decision-making with cancer patients aged 65 years and older: a pilot study.

Authors:  Noralie H Geessink; Yvonne Schoon; Marcel Gm Olde Rikkert; Harry van Goor
Journal:  Cancer Manag Res       Date:  2017-11-10       Impact factor: 3.989

Review 5.  Exploring Cost-Effectiveness of the Comprehensive Geriatric Assessment in Geriatric Oncology: A Narrative Review.

Authors:  Sara Zuccarino; Fiammetta Monacelli; Rachele Antognoli; Alessio Nencioni; Fabio Monzani; Francesca Ferrè; Chiara Seghieri; Raffaele Antonelli Incalzi
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 6.  Use of Comprehensive Geriatric Assessment in Oncology Patients to Guide Treatment Decisions and Predict Chemotherapy Toxicity.

Authors:  Gobind R Tarchand; Vicki Morrison; Mark A Klein; Elyse Watkins
Journal:  Fed Pract       Date:  2021-05

7.  Perceptions of Older Adult Care Among Ambulatory Oncology Nurses.

Authors:  Elizabeth Capezuti; Mary Elizabeth Davis; Lara Wahlberg; Theresa Lundy; Lorraine K McEvoy
Journal:  Cancer Nurs       Date:  2022 Jan-Feb 01       Impact factor: 2.760

8.  Exploring Determinants of Interdisciplinary Collaboration within a Geriatric Oncology Setting: A Mixed-Method Study.

Authors:  Marion Barrault-Couchouron; Noemi Micheli; Pierre Soubeyran
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.